Navigation Links
Appointment of Chief Executive Officer
Date:9/19/2011

re delighted to announce the appointment of Thomas as CEO. This successfully completes the reorganisation announced earlier this year in order to streamline Silence's operations. Now that Silence has become a wholly European company it is appropriate to have a Chief Executive based in Europe. Thomas has more than 10 years of experience at Silence as CFO, COO and since 2006 as CEO of Silence Therapeutics AG and was instrumental in Silence's major partnerships with pharmaceutical companies. His experience with the team and the science will ensure continuity as we move forward.We are confident that Thomas has the vision, expertise and experience necessary to move the Company toward the achievement of its corporate and clinical objectives."

Commenting on his appointment, Thomas Christély said:"I am delighted to have been appointed CEO of Silence at this very exciting time for the Company.During my time so far at Silence, the Company has made significant clinical progress and now has an enviable portfolio of clinical and pre-clinical assets.  With my long term relationships already established with our partners over many years, I look forward to achieving further commercial success from this outstanding pipeline."

Thomas Christély holds 500,000 shares (0.09% of issued share capital) in Silence.  No further disclosures are required under AIM Rule 17.

Notes for editors                    

About Silence Therapeutics plc (http://www.silence-therapeutics.com)

Silence Therapeutics plc (AIM: SLN) is a leading biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. Silence offers one of the most comprehensive short interfering RNA (siRNA) th
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
2. ADVENTRX Announces Appointment of Senior Vice President, Commercial
3. Saladax Biomedical, Inc. Announces Appointment of Gregory C. Critchfield, M.D., M.S. as Chairman of the Companys Board of Directors
4. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
5. Access Legal Announces Appointment of Nicholas Tubb to Medical Negligence Team
6. OncoSec Announces Clinical Leadership Appointments
7. Biomatrica Announces the Appointment of Dr. James A. Robb as a Member of the Scientific Advisory Board
8. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
9. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
10. OncoSec Announces Leadership Team Appointments
11. ERT Announces Appointment of New President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Va. , March 5, 2015   HX360 ... as semi-finalists in the HX360 Innovation Challenge ... entries, will compete to be chosen as one of ... panel of senior health system executives and venture capitalists ... HX360 Innovation Challenge takes place at the 2015 HIMSS ...
(Date:3/5/2015)... York (PRWEB) March 05, 2015 LifeCell ... to be able to get an Advanced Semen Analysis ... stress, blaming and guessing are all risk factors for ... the woman is the source of the infertility. Infertility ... LifeCell Dx has the simplest, least complicated and ...
(Date:3/5/2015)... 2015 Plant disease specialists from around ... the Annual Meeting of The American Phytopathological Society. ... online now at APSnet.org/meet . , The Preliminary ... to be held August 1-5, 2015 in Pasadena, California, ... Trips, Workshops, and committee meetings, all carefully balanced to ...
(Date:3/5/2015)... Springs, FL (PRWEB) March 05, 2015 ... Damm for the position of Vice President of Managed ... managed care relationships for one of the nation’s leading ... brings more than 15 years of specialty pharmacy and ... Damm worked with Raptor Pharmaceuticals, Vertex Pharmaceuticals, and Pfizer. ...
Breaking Biology Technology:HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4LifeCell Dx Offers New Option to Veterans with Infertility 2LifeCell Dx Offers New Option to Veterans with Infertility 3American Phytopathological Society Announces Annual Meeting Daily Schedule 2BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2
... NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. ... an agreement with UK-based Scancell Ltd., the operating ... developing therapeutic cancer and infectious disease vaccines. This ... IVT,s DepoVax(TM) delivery system for Scancell,s novel ImmunoBody(R) ...
... - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: ... oncology, will announce its second quarter 2009 financial and operating ... Company will host a conference call and webcast to discuss ... Time. , Participants may access the live webcast via the ...
... , NEW HAVEN, Conn., Aug. 5 Rib-X ... on the discovery, development and commercialization of novel antibiotics for ... a Phase 2 clinical trial of radezolid in the treatment ... In the double-blind study, radezolid was administered orally at three ...
Cached Biology Technology:ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery 2Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 2Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 3Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia 4
(Date:3/5/2015)... In Brazil , cloud computing ... these solutions and 42 percent planning to invest in them ... percent of the companies will be investing in these solutions ... companies in the region are currently opting for the private ... command significant attention in the coming years. This trend is ...
(Date:3/4/2015)... 2015 Research and Markets ( ... "Global Biometrics Market Forecast and Opportunities, 2020" ... market for biometric authentication systems is projected to ... 2020 The driving forces for this ... government projects and constant development in technology. In ...
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... a person,s body mass consisting of skeletal muscle, chronic ... in the limbs can result in significant physical ... community health professor Kimberly Huey, past research has demonstrated ... associated with reduced expression of certain pro-inflammatory cytokines, in ...
... tool to monitor deforestation and degradation in tropical ... Gordon and Betty Moore Foundation has awarded the ... $1.6-million grant to expand and improve CLASLite (The ... method that enables even the smallest governments and ...
... site today, it,s easy to forget that a dam and ... Franbrook Farm Research Station in southwestern Wisconsin. All traces of ... and weedy, now carpet the floor of the former basin. ... into the soils of the basin, UW-Madison researchers are now ...
Cached Biology News:Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3Tropical forest carbon monitoring gets big boost 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Rabbit polyclonal to ATF4 (phospho S245) ( Abpromise for all tested applications). Antigen: Synthetic phosphopeptide derived from human ATF4 around the phosphorylation site of Serine 245. En...
Evolutionarily conserved signaling intermediate in Toll pathway...
Biology Products: